Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

taletrectinib MeSH Supplementary Concept Data 2025


MeSH Supplementary
taletrectinib
Unique ID
C000720459
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000720459
Entry Term(s)
3-(4-((2R)-2-aminopropoxy)phenyl)-N-((1R)-1-(3-fluorophenyl)ethyl)imidazo(1,2-b)pyridazin-6-amine;hexanedioic acid
Registry Numbers
W4141180YD
Heading Mapped to
*Imidazoles
*Pyridazines
Frequency
1
Note
type I ROS1-NTRK inhibitor
Source
Clin Cancer Res . 2020 Sep 15;26(18):4785-4794.
Date of Entry
2021/12/15
Revision Date
2021/12/15
taletrectinib Preferred
3-(4-((2R)-2-aminopropoxy)phenyl)-N-((1R)-1-(3-fluorophenyl)ethyl)imidazo(1,2-b)pyridazin-6-amine;hexanedioic acid Broader
page delivered in 0.006s